Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing

Overview of attention for article published in Clinical Cancer Research, September 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 26 X users

Readers on

mendeley: 71 Mendeley

So far, Altmetric has seen 34 X posts from 26 X users, with an upper bound of 85,688 followers.

RT @JBrosnanCashman: Fantastic overview of #clinicaltrials in patients with lenalidomide refractory #myeloma by Dr. Francesca Gay. Be sure…

Fantastic overview of #clinicaltrials in patients with lenalidomide refractory #myeloma by Dr. Francesca Gay. Be sure to read her recent paper in @CCR_AACR. #AACRMDT21 @unito https://t.co/g0njQWt6mK

Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. #AACRMDT21 https://t.co/dlA24Uw0GS https://t.co/nbfXgVkXtX

Dr. Mattia D’Agostino et al. characterized multiple #myeloma patients with early progressive disease in the CoMMpass study to identify factors associated with high-risk disease @unito @CCR_AACR #mmsm #AACRMDT21 https://t.co/vE47judZPW

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 30 additional X posts.